临床研究
ENGLISH ABSTRACT
两个汉族家族性玻璃体淀粉样变性家系突变基因检测及临床表型分析
郑巍
李海波
张雪咏
周学智
陈媛媛
毛俊峰
作者及单位信息
·
DOI: 10.3760/cma.j.cn115989-20190721-00318
Genetic testing and clinical phenotypic analysis of familial vitreous amyloidosis in two Han Chinese families
Zheng Wei
Li Haibo
Zhang Xueyong
Zhou Xuezhi
Chen Yuanyuan
Mao Junfeng
Authors Info & Affiliations
Zheng Wei
Department of Ophthalmology, Xiangya Hospital of Central South University, Changsha 410008, China
Li Haibo
Department of Ophthalmology, Xiangya Hospital of Central South University, Changsha 410008, China
Zhang Xueyong
Department of Ophthalmology, Xiangya Hospital of Central South University, Changsha 410008, China
Zhou Xuezhi
Department of Ophthalmology, Xiangya Hospital of Central South University, Changsha 410008, China
Chen Yuanyuan
Department of Ophthalmology, Xiangya Hospital of Central South University, Changsha 410008, China
Mao Junfeng
Department of Ophthalmology, Xiangya Hospital of Central South University, Changsha 410008, China
·
DOI: 10.3760/cma.j.cn115989-20190721-00318
322
44
0
0
0
0
PDF下载
APP内阅读
摘要

目的探讨2个汉族家族性玻璃体淀粉样变性(FVA)家系的临床特征及其基因突变特点。

方法采用家系调查研究,收集2015年1月至2018年12月于中南大学湘雅医院就诊的2个汉族淀粉样变性家系,对家系成员进行全身及眼科检查,抽取外周静脉血,进行DNA抽提、PCR扩增、筛选及测序等检测转甲状腺素蛋白( TTR)基因。分别对2个家系的先证者行经睫状体平坦部标准三通道23G玻璃体切割术,术后对玻璃体样本行组织病理学检查。

结果家系1的63名成员中有15例出现双眼玻璃体混浊,平均发病年龄为(43.6±5.8)岁;全身检查未发现神经系统、心血管系统、肾脏、肝脏病变;先证者术中玻璃体黏稠,难以切净;玻璃体标本刚果红染色呈阳性;术后伴发开角型青光眼,基因检测发现 TTR基因第3外显子Gly83Arg突变。家系2的49名成员中有7例出现双眼玻璃体混浊,平均发病年龄为(50.4±5.5)岁;其中3例患者出现四肢麻木、肌力下降症状。先证者术中见玻璃体松软易于切割,玻璃体标本刚果红染色呈阳性反应,基因检测发现 TTR基因第2外显子Ala36Pro突变,未伴发青光眼。

结论 TTR基因Gly83Arg或Ala36Pro突变可导致FVA,2个家系致病基因位点不同,其发病年龄、临床症状、并发其他系统疾病等临床表型也有所不同。

玻璃体淀粉样变性;临床表型;转甲状腺素蛋白;基因突变;汉族;家系分析
ABSTRACT

ObjectiveTo investigate the clinical characteristics of two Han families with familial vitreous amyloidosis (FVA) and the gene mutation.

MethodsA pedigree investigation was performed.Two Han Chinese families with FVA treated in Xiangya Hospital of Central South University from January 2015 to December 2018 were collected.General examination and ophthalmic examination were performed among 112 members of the two families.Peripheral blood samples were collected from 32 family members (15 patients in MZ001 pedigree, 7 patients in MZ002 pedigree, and 5 persons with normal clinical phenotype from each pedigree) for DNA extraction, polymerase chain reaction (PCR) amplification, transthyretin ( TTR) gene screening and sequencing.Vitreous biopsy following three-channel 23-gauge pars plana vitrectomy was performed on the two probands in the two families.Vitreous specimens were sent for pathological examination.This study adhered to the Declaration of Helsinki.The study protocol was approved by an Ethics Committee of Xiangya Hospital of Central South University (No.201412463), and written informed consent was obtained from all subjects before any medical examination.

ResultsIn MZ001, there were 15 cases of the 63 members presented bilateral vitreous opacity at an average age of (43.6±5.8) years.No lesion was found in nervous system, cardiovascular system, kidney or liver in general inspection.The vitreous of the proband (Ⅲ13) was so sticky that could not be totally removed during vitrectomy.The vitreous specimen showed positive Congo red staining.Ⅲ13 had elevated intraocular pressure after vitrectomy and was diagnosed as open-angle glaucoma.Gene sequencing revealed Gly83Arg mutation in the exon 3 of TTR gene.In MZ002, 7 cases of 49 members had bilateral vitreous opacity at an average age of (50.4±5.5) years, among which, 3 cases appeared symptoms of limb numbness and decreased muscle strength.The vitreous body of the proband (Ⅱ11) in MZ002 pedigree was looser and easier to remove during vitrectomy than that of Ⅲ13 in MZ001 pedigree.Vitreous specimen of Ⅱ11 was positive with Congo red staining.Gene sequencing revealed an Ala36Pro variant in the exon 3 of TTR gene.

ConclusionsGly83Arg or Ala36Pro mutation of TTR gene can cause FVA.Different mutations can lead to different clinical phenotypes such as age of onset, clinical symptoms and complications of other systems.

Vitreous amyloidosis;Clinical phenotype;Transthyretin;Genetic mutation;Han nationality;Pedigree study
Mao Junfeng, Email: mocdef.3ab61gnefnuj_oam
引用本文

郑巍,李海波,张雪咏,等. 两个汉族家族性玻璃体淀粉样变性家系突变基因检测及临床表型分析[J]. 中华实验眼科杂志,2021,39(08):714-718.

DOI:10.3760/cma.j.cn115989-20190721-00318

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
家族性玻璃体淀粉样变性(familial vitreous amyloidosis,FVA)是一种罕见的常染色体显性遗传疾病,因淀粉样物质在玻璃体内的沉积而致病,可独立发病,也可同时累及全身多个器官和组织 [ 1 ],其发病与转甲状腺素蛋白(transthyretin, TTR)基因突变密切相关。TTR主要由肝脏(约占90%)、脉络丛及视网膜色素上皮细胞合成,目前已报道的 TTR基因致病性突变有100多种,存在一定的种族及地域差异性 [ 2 , 3 , 4 ]。本研究收集并分析2个FVA家系的临床资料,以进一步探讨我国汉族人群玻璃体淀粉样变性的临床特征及基因突变位点。
参考文献
[1]
Venkatesh P , Selvan H , Singh SB ,et al. Vitreousamyloidosis: ocular, systemic, and genetic insights[J]. Ophthalmology, 2017,124(7):1014-1022. DOI: 10.1016/j.ophtha.2017.03.011 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Benson MD , Kincaid JC . The molecular biology and clinical features of amyloid neuropathy[J]. Muscle Nerve, 2007,36(4):411-423. DOI: 10.1002/mus.20821 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Liu T , Zhang B , Jin X ,et al. Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation [J]. Eye (Lond), 2014,28(1):26-33. DOI: 10.1038/eye.2013.217 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Benson MD . Ostertag revisited: the inherited systemic amyloidoses without neuropathy[J]. Amyloid, 2005,12(2):75-87. DOI: 10.1080/13506120500106925 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Sipe JD , Benson MD , Buxbaum JN ,et al. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines[J]. Amyloid, 2016,23(4):209-213. DOI: 10.1080/13506129.2016.1257986 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Planté-Bordeneuve V , Said G . Familial amyloid polyneuropathy[J]. Lancet Neurol, 2011,10(12):1086-1097. DOI: 10.1016/S1474-4422(11)70246-0 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Long D , Zeng J , Wu LQ ,et al. Vitreous amyloidosis in two large mainland Chinese kindreds resulting from transthyretin variant Lys35Thr and Leu55Arg[J]. Ophthalmic Genet, 2012,33(1):28-33. DOI: 10.3109/13816810.2011.599356 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
陈凌燕吕林张平玻璃体淀粉样变性伴转甲蛋白Arg-83突变一例[J]眼科学报 200824(1):65-67. DOI: 10.3969/j.issn.1000-4432.2008.01.016 .
返回引文位置Google Scholar
百度学术
万方数据
Chen LY , L , Zhang P ,et al. Transthyretin Arg-83 mutation in vitreous amyloidosis[J]. Eye Sci, 2008,24(1):65-67. DOI: 10.3969/j.issn.1000-4432.2008.01.016 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[9]
徐江宁周青青杨正林家族性玻璃体淀粉样变性一家系的临床特征及基因分析[J]中华实验眼科杂志 201331(5):471-475. DOI: 10.3760/cma.j.issn.2095-0160.2013.05.013 .
返回引文位置Google Scholar
百度学术
万方数据
Xu JN , Zhou QQ , Yang ZL ,et al. Clinical characteristics and gene analysis of vitreous amyloidosis in a Chinese kindreds[J]. Chin J Exp Ophthalmol, 2013,31(5):471-475. DOI: 10.3760/cma.j.issn.2095-0160.2013.05.013 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[10]
Zhang AM , Wang H , Sun P ,et al. Mutation p. G83R in the transthyretin gene is associated with hereditary vitreous amyloidosis in Han Chinese families[J]. Mol Vis, 2013,19:1631-1638.
返回引文位置Google Scholar
百度学术
万方数据
[11]
谢兵蔡善君郑志涌家族性玻璃体淀粉样变性甲状腺激素结合蛋白Gly83Arg突变一家系[J]中华眼底病杂志 201632(3):312-314. DOI: 10.3760/cma.j.issn.1005-1015.2016.03.021 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Zou X , Dong F , Zhang S ,et al. Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor[J]. Exp Eye Res, 2013,110:44-49. DOI: 10.1016/j.exer.2013.02.005 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Liu G , Ni W , Wang H ,et al. Clinical features of familial amyloid polyneuropathy carrying transthyretin mutations in four Chinese kindreds[J]. J Peripher Nerv Syst, 2017,22(1):19-26. DOI: 10.1111/jns.12196 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Liu YT , Lee YC , Yang CC ,et al. Transthyretin Ala97Ser in Chinese-Taiwanese patients with familial amyloid polyneuropathy: genetic studies and phenotype expression[J]. J Neurol Sci, 2008,267(1-2):91-99. DOI: 10.1016/j.jns.2007.10.011 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Zhang Y , Deng YL , Ma JF ,et al. Transthyretin-related hereditary amyloidosis in a Chinese family with TTR Y114C mutation [J]. Neurodegener Dis, 2011,8(4):187-193. DOI: 10.1159/000321679 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Ran LX , Zheng ZY , Xie B ,et al. A mouse model of a novel missense mutation (Gly83Arg) in a Chinese kindred manifesting vitreous amyloidosis only[J]. Exp Eye Res, 2018,169:13-19. DOI: 10.1016/j.exer.2018.01.017 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
You J . Vitrectomy for vitreous amyloidosis[J]. Int J Ophthalmol, 2011,4(3):307-310. DOI: 10.3980/j.issn.2222-3959.2011.03.20 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
李中文吴雪芳潘涵英玻璃体切割术治疗玻璃体淀粉样变性的疗效分析[J]中华实验眼科杂志 201634(8):720-723. DOI: 10.3760/cma.j.issn.2095-0160.2016.08.011 .
返回引文位置Google Scholar
百度学术
万方数据
Li ZW , Wu XF , Pan HY ,et al. Efficacy of vitrectomy for vitreous amyloidosis[J]. Chin J Exp Ophthalmol, 2016,34(8):720-723. DOI: 10.3760/cma.j.issn.2095-0160.2016.08.011 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[19]
Kimura A , Ando E , Fukushima M ,et al. Secondary glaucoma in patients with familial amyloidotic polyneuropathy[J]. Arch Ophthalmol, 2003,121(3):351-356. DOI: 10.1001/archopht.121.3.351 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
毛俊峰,Email: mocdef.3ab61gnefnuj_oam
B
所有作者均声明不存在任何利益冲突
C
湖南省卫计委项目 (B20180915)
长沙市自然科学基金项目 (kq2014292)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号